Can high ApoB-containing lipoprotein burden promote arterial wall retention and immune activation?

Atherogenesis is initiated by the physical entrapment of apolipoprotein B (ApoB)-containing lipoproteins—including low-density lipoprotein particles (LDL-P) and lipoprotein(a) [Lp(a)]—within the subendothelial space.

Subendothelial retention and oxidation

• Proteoglycan binding: Once transcytosed across the vascular endothelium, ApoB-containing particles are retained via electrostatic interactions between the positively charged Site B domain of ApoB (residues 3359–3369) and negatively charged glycosaminoglycan (GAG) chains on proteoglycans.
• Chemical modification: This immobilization increases the subendothelial residence time of the particles, directly facilitating their chemical modification and oxidation into oxidized LDL (oxLDL) and highly bioactive oxidized phospholipids (OxPLs).

Innate immune activation and foam cell formation

• Scavenger receptor engagement: Intimal macrophages recognize oxLDL as danger-associated molecular patterns (DAMPs). Unregulated endocytosis via scavenger receptors, primarily CD36, leads to massive cholesteryl ester accumulation and foam cell formation.
• Pro-inflammatory signaling: OxLDL and OxPLs (which are highly enriched on Lp(a)) bind to Toll-like receptors (TLR2 and TLR4), initiating intracellular cascades that activate the transcription factor NF-κB.
• Inflammasome activation: These oxidation products also provide critical priming and activation signals for the NLRP3 inflammasome, culminating in the maturation and secretion of interleukins IL-1β and IL-18 to drive localized vascular inflammation.

Bottom line

• Elevated ApoB particle burden directly accelerates atherosclerosis by promoting electrostatic subendothelial entrapment, which allows prolonged exposure to oxidative forces and subsequently triggers macrophage foam cell formation and TLR/NLRP3-mediated arterial wall inflammation.